The baseline blood panel: what to test before any peptide protocol
The short version: you cannot measure progress without a starting number.
TL;DR
- A baseline blood panel anchors a peptide protocol in numbers, not impressions.
- Core panel: CMP, lipid panel, A1C, fasting insulin, IGF-1, sex hormones, hs-CRP.
- Re-test the relevant subset at 8–12 weeks to see what changed.
What it is
A baseline blood panel is the set of lab tests drawn before a peptide protocol begins. It captures where your body is right now so any change can be measured against it later. The standard panel is built from broadly available, well-validated tests — most are covered by major insurance and commonly run by primary care.
How it works
Think of it like weighing your luggage before a trip. The number itself is not the point. The point is being able to say at the end of the trip whether anything was added or removed. Each test in the panel measures one specific system: CMP (in plain English: a 14-test panel covering kidney function, liver function, electrolytes, and glucose) checks general organ function (MedlinePlus, CMP, 2024); the lipid panel measures cholesterol and triglycerides (CDC, Cholesterol Screening, 2024); A1C and fasting insulin map metabolic health; IGF-1 reflects the growth hormone axis; sex hormones map the reproductive axis; hs-CRP reflects inflammation.
Who asks about it
People ask this when their clinician requests labs and they want to know which tests are core, which are optional, and why each one is on the list.
What the research says
The CMP and lipid panel are foundational because they are the most extensively validated reference tests in adult medicine. A1C reflects the average blood glucose over roughly the prior 90 days and is the standard diagnostic for type 2 diabetes. Fasting insulin is included because it can detect insulin resistance years before A1C moves out of normal range. IGF-1 is included for any growth-hormone-axis peptide because it is the downstream signal those peptides ultimately influence.
What to know before considering it
A baseline panel is not a substitute for a clinician evaluation — it is an input to one. Lab values vary by lab and reference range, and some peptide-relevant markers (fasting insulin, hs-CRP, IGF-1) are not always part of a generic primary-care panel.
The Halftime POV
If your clinic is willing to start a protocol without baseline labs, that is a signal. Quality care starts with numbers.
Related reading:
- Biomarkers commonly tracked during peptide protocols
- IGF-1 lab test: what the number means
- A1C and fasting glucose: the two metabolic baselines
FAQ
Q: What labs should I get before starting peptide therapy? A: A typical baseline panel includes a comprehensive metabolic panel, lipid panel, A1C, fasting insulin, IGF-1, total and free testosterone (men) or estradiol/progesterone (women), and hs-CRP. Your clinician will tailor the list to your goals.
Q: Why do I need a baseline panel? A: Without a starting number, you cannot tell whether a peptide is working. Baseline labs give you a comparison point at 8–12 weeks and flag any safety issues that change the protocol decision.
Q: How fresh do baseline labs need to be? A: Most clinicians prefer labs drawn within the last 60–90 days. Older labs do not reflect current physiology and are not a fair comparison after a protocol begins.
Disclaimer
This article is educational and is not medical advice. Compounded medications are not FDA-approved. Clinical outcomes depend on individual factors and require physician evaluation. Results vary. Halftime Health is launching soon — join the waitlist to get updates.
Get updates
Halftime Health is launching soon. We’ll share what we learn along the way — the research, the regulations, the real-world trade-offs. Join the waitlist and we’ll email you when we’re live.
